In Parkinson’s disease rats, MIAT downregulation was observed in the striatum, substantia nigra, hippocampus, and cortex compared with normal rats, and its upregulation was associated with increased cellular viability and decreased apoptosis, proposing the neuroprotective role of lncRNA MIAT in Parkinson’s disease [71]. Here, MIAT is linked to Parkinson disease.